when was semaglutide patented Patent expires next year: Novo Nordisk faces tough competition in the Chinese obesity market Novo Nordisk Settles Ozempic Patent

The unprecedented demand for glucagon-like peptide-1 (GLP-1) receptor agonists, specifically semaglutide and tirzepatide, has transformed what was once a niche practice of customized medication into a multi-billion-dollar shadow industry

If you eventually achieve your health goals and discontinue GLP-1 therapy, cholesterol gains may partially reverse unless you sustain the weight loss through diet and exercise

Our commitment to purity extends to empowering you with best practices for maintaining it

CGM also serves as an educational tool for lifestyle modification, providing real-time feedback that helps patients understand how diet and physical activity affect glucose levels